Identification of a clinical subset of systemic lupus erythematosus by antibodies to the sm antigen
β Scribed by Donna M Winn; J Frederick Wolfe; Donald A Lindberg; Frank H Fristoe; Larry Kingsland; Dr. Gordon C Sharp
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 298 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The clinical and renal histologic attributes of 135 systemic lupus erythematosus (SLE) patients with DNA and/or Sm antibodies were compared to determine if the presence of the Sm antibodies served as a marker for a specific subset of SLE. Although Raynaud's phenomenon was more frequent in patients with Sm antibodies (P < 0.005), serious central nervous system disease was over three times as common in patients with DNA antibodies (P < 0.005). Only one of 23 patients with Sm antibodies had diffuse proliferative glomerulonephritis on renal biopsy, whereas 6 of 14 patients with only DNA antibodies had this histologic finding (P = 0.01). The Sm antibody system may therefore identify a subset of SLE patients with milder central nervous system and renal disease.
π SIMILAR VOLUMES
## Objective: To determine whether antiphospholipid antibodies (apl) occur before the diagnosis of systemic lupus erythematosus (sle) and before initial clotting events, and whether their presence early in the disease course influences clinical outcome. ## Methods: Serum samples obtained from 130
We describe a patient with systemic lupus erythematosus who, after a disease flare, sequentially produced antibodies to specific Sm polypeptides (demonstrated by counterimmunoelectrophoresis, immunoblotting, and RNA immunoprecipitation) concomitantly with the disappearance of anti-double-stranded DN